Smoking and thyroid
Summary Current smoking in population surveys is associated with a slight dose‐dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in s...
Saved in:
| Published in | Clinical endocrinology (Oxford) Vol. 79; no. 2; pp. 145 - 151 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Oxford
Blackwell Publishing Ltd
01.08.2013
Blackwell Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Summary
Current smoking in population surveys is associated with a slight dose‐dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine‐deficient but not in iodine‐sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine‐deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti‐inflammatory effects of nicotine are involved. In contrast, smoking is a dose‐dependent risk factor for Graves’ hyperthyroidism and especially for Graves’ ophthalmopathy. Smoking is related to a higher recurrence rate of Graves’ hyperthyroidism, a higher risk on Graves’ ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose–response effects and disappearance of associations after cessation of smoking. |
|---|---|
| AbstractList | Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine-deficient but not in iodine-sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine-deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti-inflammatory effects of nicotine are involved. In contrast, smoking is a dose-dependent risk factor for Graves' hyperthyroidism and especially for Graves' ophthalmopathy. Smoking is related to a higher recurrence rate of Graves' hyperthyroidism, a higher risk on Graves' ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose-response effects and disappearance of associations after cessation of smoking.Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine-deficient but not in iodine-sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine-deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti-inflammatory effects of nicotine are involved. In contrast, smoking is a dose-dependent risk factor for Graves' hyperthyroidism and especially for Graves' ophthalmopathy. Smoking is related to a higher recurrence rate of Graves' hyperthyroidism, a higher risk on Graves' ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose-response effects and disappearance of associations after cessation of smoking. Summary Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine-deficient but not in iodine-sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine-deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti-inflammatory effects of nicotine are involved. In contrast, smoking is a dose-dependent risk factor for Graves' hyperthyroidism and especially for Graves' ophthalmopathy. Smoking is related to a higher recurrence rate of Graves' hyperthyroidism, a higher risk on Graves' ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose-response effects and disappearance of associations after cessation of smoking. [PUBLICATION ABSTRACT] Summary Current smoking in population surveys is associated with a slight dose‐dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine‐deficient but not in iodine‐sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine‐deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti‐inflammatory effects of nicotine are involved. In contrast, smoking is a dose‐dependent risk factor for Graves’ hyperthyroidism and especially for Graves’ ophthalmopathy. Smoking is related to a higher recurrence rate of Graves’ hyperthyroidism, a higher risk on Graves’ ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose–response effects and disappearance of associations after cessation of smoking. Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine-deficient but not in iodine-sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine-deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti-inflammatory effects of nicotine are involved. In contrast, smoking is a dose-dependent risk factor for Graves' hyperthyroidism and especially for Graves' ophthalmopathy. Smoking is related to a higher recurrence rate of Graves' hyperthyroidism, a higher risk on Graves' ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose-response effects and disappearance of associations after cessation of smoking. Current smoking in population surveys is associated with a slight dose‐dependent fall of serum TSH , likely secondary to a rise of serum FT 4 and FT 3 induced by activation of the sympathetic nervous system; it is independent of iodine intake. In contrast, the slightly greater thyroid size in smokers is observed in iodine‐deficient but not in iodine‐sufficient areas and caused by competitive inhibition of thyroidal iodide uptake by thiocyanate. Smokers have an increased prevalence of nontoxic goitre and thyroid multinodularity, at least in iodine‐deficient areas. Current smoking reduces dose dependently the risk of thyroid cancer, which is more pronounced for papillary than for follicular types; the risk in former smokers approaches that of never smokers. The lower TSH and lower body mass index in smokers might contribute to this reduced risk. Current smoking lowers the risk of developing thyroid peroxidase and thyroglobulin antibodies and subclinical and overt autoimmune hypothyroidism; the effect is dose dependent, but disappears within 3 years after quitting smoking. There is evidence from an animal model of experimental autoimmune thyroiditis that anti‐inflammatory effects of nicotine are involved. In contrast, smoking is a dose‐dependent risk factor for Graves’ hyperthyroidism and especially for Graves’ ophthalmopathy. Smoking is related to a higher recurrence rate of Graves’ hyperthyroidism, a higher risk on Graves’ ophthalmopathy after 131I therapy and a less favourable outcome of GO treatment with steroids or retrobulbar irradiation. The observed associations with smoking likely indicate causal relationships in view of consistent associations across studies, the presence of dose–response effects and disappearance of associations after cessation of smoking. |
| Author | Wiersinga, Wilmar M. |
| Author_xml | – sequence: 1 givenname: Wilmar M. surname: Wiersinga fullname: Wiersinga, Wilmar M. email: w.m.wiersinga@amc.uva.nl organization: Department of Endocrinology & Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27517202$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23581474$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90E1LAzEQBuAgirbqQbyLIIIe1uY7m6OUtiqiiIrHkM1mNbrN1mSL9t8bba0g6FxC4Hknk-mCVd94C8AOgicoVc9Yf4JwqhXQQYSzDGPOVkEHEggzyDndAN0YnyGELIdiHWxgwnJEBe2A3dtx8-L847725X77NAuNK7fAWqXraLcX5ya4Hw7u-mfZ5fXovH96mRmW3sos5sLICtsCScFKzAuKeboTbssCEZoLWVFUCmag4EZIQow0sKxwJfOCI002wdG87yQ0r1MbWzV20di61t4206gQkVJiKgRK9OAXfW6mwafpFGJYMgEJ_1R7CzUtxrZUk-DGOszU93cTOFwAHY2uq6C9cfHHCYYEhji547kzoYkx2GpJEFSfK1dp5epr5cn2flnjWt26xrdBu_q_xJur7ezv1qo_uPpOZPOEi619XyZ0eFFcEMHUw9VIUQwvcjq8UX3yARe7m1Y |
| CODEN | CLECAP |
| CitedBy_id | crossref_primary_10_1007_s42000_023_00498_8 crossref_primary_10_2147_JIR_S307046 crossref_primary_10_3109_15569527_2014_975240 crossref_primary_10_1097_IOP_0000000000001136 crossref_primary_10_1097_IOP_0000000000002467 crossref_primary_10_1111_head_12943 crossref_primary_10_1007_s40618_018_0915_z crossref_primary_10_1056_NEJMra1510030 crossref_primary_10_1016_j_talanta_2017_05_007 crossref_primary_10_2337_dc19_2429 crossref_primary_10_1186_1687_9856_2014_8 crossref_primary_10_1007_s00262_024_03816_0 crossref_primary_10_1007_s12011_023_03635_x crossref_primary_10_1016_j_biopha_2017_08_101 crossref_primary_10_1038_s41416_018_0224_5 crossref_primary_10_1186_s12902_019_0414_z crossref_primary_10_1136_bjophthalmol_2014_305649 crossref_primary_10_1136_bjo_2022_322442 crossref_primary_10_1186_s40662_014_0009_8 crossref_primary_10_1016_j_diabet_2014_11_009 crossref_primary_10_7759_cureus_56020 crossref_primary_10_1016_j_ajo_2023_01_020 crossref_primary_10_7861_clinmedicine_15_2_173 crossref_primary_10_1097_MED_0000000000000088 crossref_primary_10_3803_EnM_2021_954 crossref_primary_10_1186_s12902_016_0127_5 crossref_primary_10_12998_wjcc_v11_i5_1058 crossref_primary_10_3390_ijms22126521 crossref_primary_10_1016_j_ijheh_2025_114544 crossref_primary_10_1111_cen_12279 crossref_primary_10_1007_s10792_019_01258_7 crossref_primary_10_1007_s12020_016_1136_x crossref_primary_10_1038_nrendo_2018_18 crossref_primary_10_1055_a_1328_2884 crossref_primary_10_1155_2017_8401518 crossref_primary_10_1155_2021_9964232 crossref_primary_10_3389_fendo_2023_1186105 crossref_primary_10_1016_j_neuropharm_2015_01_026 crossref_primary_10_3390_jcm12072640 crossref_primary_10_3803_EnM_2016_31_2_213 crossref_primary_10_2967_jnumed_120_243170 crossref_primary_10_1016_S1636_5410_18_91423_6 crossref_primary_10_1055_a_1743_2988 crossref_primary_10_14341_ket12776 crossref_primary_10_1210_js_2019_00155 crossref_primary_10_1038_s41433_018_0242_9 crossref_primary_10_1177_11206721231199868 crossref_primary_10_1111_cen_12746 crossref_primary_10_1016_j_aggp_2025_100129 crossref_primary_10_1002_fsn3_3538 crossref_primary_10_3413_Nukmed_0739_15_04 crossref_primary_10_1055_a_1861_7315 crossref_primary_10_1016_S0140_6736_16_00278_6 crossref_primary_10_3390_cancers13215444 crossref_primary_10_1093_ntr_ntu229 crossref_primary_10_1177_11795514241299709 crossref_primary_10_18332_tid_130350 crossref_primary_10_1007_s40618_024_02332_3 crossref_primary_10_1016_j_mpdhp_2024_03_001 crossref_primary_10_4103_tjo_tjo_10_20 crossref_primary_10_1007_s40618_014_0214_2 crossref_primary_10_1089_gtmb_2023_0594 crossref_primary_10_1002_ijc_30088 crossref_primary_10_1016_j_autrev_2014_01_007 crossref_primary_10_35371_aoem_2021_33_e32 crossref_primary_10_4103_tjo_tjo_3_21 crossref_primary_10_1210_clinem_dgad538 crossref_primary_10_1038_s41598_018_31253_4 crossref_primary_10_6065_apem_2244186_093 crossref_primary_10_22141_2309_8147_11_3_2023_343 crossref_primary_10_1097_NCC_0000000000000449 crossref_primary_10_1159_000488279 crossref_primary_10_1017_S1368980015002943 crossref_primary_10_3390_nu12092656 crossref_primary_10_1016_j_ando_2014_09_002 crossref_primary_10_1016_S2213_8587_23_00005_0 crossref_primary_10_1080_17469899_2017_1276444 crossref_primary_10_1159_000509615 crossref_primary_10_1007_s12020_019_02125_2 crossref_primary_10_1530_EJE_16_0552 crossref_primary_10_1016_j_arcmed_2022_10_003 crossref_primary_10_1155_2016_8129497 crossref_primary_10_1111_cen_13606 crossref_primary_10_1097_EDE_0000000000000937 crossref_primary_10_12677_ACM_2022_123326 crossref_primary_10_1210_clinem_dgad083 crossref_primary_10_3390_toxics8040116 crossref_primary_10_1177_8756479318824290 crossref_primary_10_1016_j_jpsychires_2018_09_014 crossref_primary_10_3389_fendo_2020_615993 crossref_primary_10_1111_mcn_12470 crossref_primary_10_1016_j_npep_2022_102308 crossref_primary_10_1016_j_jcjo_2019_01_007 crossref_primary_10_1016_j_micpath_2018_01_004 crossref_primary_10_1089_thy_2019_0641 crossref_primary_10_1038_s41433_023_02513_z crossref_primary_10_1007_s40618_016_0516_7 crossref_primary_10_1210_clinem_dgad558 crossref_primary_10_1038_s41433_018_0320_z crossref_primary_10_3390_biomedicines12081788 crossref_primary_10_1155_2024_8000359 crossref_primary_10_1210_clinem_dgae763 crossref_primary_10_3389_fendo_2020_608428 crossref_primary_10_1017_S1368980019000399 crossref_primary_10_1111_cen_13750 crossref_primary_10_1089_thy_2022_0528 crossref_primary_10_3389_fnut_2023_1104925 crossref_primary_10_1371_journal_pone_0225435 crossref_primary_10_1007_s10792_022_02468_2 crossref_primary_10_1530_EJE_13_0811 crossref_primary_10_1007_s12445_015_0203_5 crossref_primary_10_1089_thy_2016_0133 crossref_primary_10_1016_j_autrev_2016_01_001 crossref_primary_10_2139_ssrn_4184813 crossref_primary_10_1016_j_toxlet_2016_06_004 crossref_primary_10_1210_clinem_dgaa956 crossref_primary_10_1530_EJE_17_0628 crossref_primary_10_1038_s41598_018_26700_1 crossref_primary_10_1097_ICU_0000000000000743 crossref_primary_10_1210_jc_2018_02303 crossref_primary_10_1016_S2213_8587_16_30046_8 crossref_primary_10_1093_hropen_hoz002 crossref_primary_10_1002_cam4_6570 crossref_primary_10_1016_j_envint_2018_08_024 crossref_primary_10_1055_s_0035_1555759 crossref_primary_10_3390_jpm13111557 crossref_primary_10_1136_bjophthalmol_2015_306733 crossref_primary_10_1159_000508071 crossref_primary_10_3803_EnM_2024_2093 crossref_primary_10_47360_1995_4484_2023_545_553 crossref_primary_10_1530_EJE_18_0039 crossref_primary_10_1016_j_eprac_2021_11_080 crossref_primary_10_1210_clinem_dgaa903 crossref_primary_10_1002_da_22692 crossref_primary_10_3390_toxics10120727 crossref_primary_10_3389_fcimb_2024_1288222 crossref_primary_10_3390_ijms232113450 crossref_primary_10_1089_thy_2014_0153 crossref_primary_10_3390_cancers13215385 crossref_primary_10_1017_S1368980014002018 crossref_primary_10_1038_s41572_020_0184_y crossref_primary_10_3803_EnM_2022_1463 crossref_primary_10_1007_s12020_021_02952_2 crossref_primary_10_1186_s12916_017_0939_9 crossref_primary_10_1016_j_ophtha_2024_01_023 crossref_primary_10_3341_kjo_2016_30_5_319 crossref_primary_10_4103_jcor_jcor_67_20 crossref_primary_10_29219_fnr_v68_9761 crossref_primary_10_1007_s12016_018_8709_9 crossref_primary_10_1007_s12285_020_00254_6 crossref_primary_10_1093_eurjpc_zwae270 crossref_primary_10_1016_j_semcancer_2013_12_001 crossref_primary_10_1007_s12011_020_02186_9 crossref_primary_10_1089_thy_2017_0567 crossref_primary_10_14260_jemds_2015_1985 crossref_primary_10_7555_JBR_38_20240421 crossref_primary_10_1016_j_jnim_2018_10_001 crossref_primary_10_1530_EC_22_0303 crossref_primary_10_1007_s12070_020_02128_w crossref_primary_10_1016_j_autrev_2020_102529 crossref_primary_10_1515_biol_2022_0671 crossref_primary_10_4049_jimmunol_1801238 crossref_primary_10_3389_fendo_2022_1029376 crossref_primary_10_1016_j_ejim_2016_04_012 crossref_primary_10_1097_IOP_0000000000000221 crossref_primary_10_1089_thy_2017_0430 crossref_primary_10_1097_IIO_0000000000000355 crossref_primary_10_1016_j_beem_2014_03_005 crossref_primary_10_1016_j_semerg_2023_102015 crossref_primary_10_1111_bjd_14470 crossref_primary_10_23736_S1824_4785_21_03350_1 crossref_primary_10_3390_biomedicines9121871 crossref_primary_10_1007_s40664_019_0353_6 crossref_primary_10_1007_s12020_023_03482_9 crossref_primary_10_1080_15569527_2023_2268162 crossref_primary_10_5114_amscd_2021_105525 crossref_primary_10_3803_EnM_2014_29_1_20 crossref_primary_10_1002_iid3_1016 crossref_primary_10_1055_a_2287_3734 crossref_primary_10_1210_jc_2017_00846 crossref_primary_10_1016_j_beem_2023_101742 crossref_primary_10_1089_thy_2018_0628 crossref_primary_10_1210_er_2013_1055 crossref_primary_10_3390_nu10030280 crossref_primary_10_1002_jcu_22802 crossref_primary_10_1038_s41598_019_40708_1 crossref_primary_10_1016_j_chemosphere_2017_12_050 crossref_primary_10_1016_j_envres_2017_04_014 crossref_primary_10_7759_cureus_71256 crossref_primary_10_1017_erm_2014_5 crossref_primary_10_1080_10408363_2022_2121960 crossref_primary_10_1111_cen_14072 crossref_primary_10_1159_000495504 crossref_primary_10_1007_s12020_023_03399_3 crossref_primary_10_1016_j_autrev_2024_103534 crossref_primary_10_1289_EHP3194 crossref_primary_10_23736_S2724_5276_22_06873_2 crossref_primary_10_1007_s40618_019_01161_z crossref_primary_10_1038_s41598_024_66937_7 crossref_primary_10_3389_fendo_2019_00933 crossref_primary_10_1016_j_envint_2022_107249 crossref_primary_10_36106_ijsr_3900902 crossref_primary_10_4158_EP14281_RA crossref_primary_10_1155_2019_4106816 crossref_primary_10_1016_j_autrev_2014_08_006 crossref_primary_10_3389_fpubh_2022_1041745 crossref_primary_10_1016_j_eprac_2024_12_007 crossref_primary_10_1111_cen_13450 crossref_primary_10_1159_000479964 crossref_primary_10_1371_journal_pone_0264388 crossref_primary_10_29219_fnr_v67_10369 crossref_primary_10_1007_s12020_020_02412_3 crossref_primary_10_1089_thy_2018_0251 crossref_primary_10_3389_fendo_2020_608733 crossref_primary_10_1080_08998280_2022_2087038 crossref_primary_10_1007_s10067_024_06888_6 crossref_primary_10_3389_fendo_2021_619568 crossref_primary_10_3389_fendo_2017_00050 crossref_primary_10_3904_kjim_2015_30_3_335 crossref_primary_10_1556_OH_2015_30064 crossref_primary_10_1038_nrendo_2016_110 crossref_primary_10_1016_j_ijheh_2024_114338 crossref_primary_10_1159_000479061 crossref_primary_10_5144_0256_4947_2018_336 crossref_primary_10_7759_cureus_13035 crossref_primary_10_1016_j_beem_2014_02_005 crossref_primary_10_1016_j_chemosphere_2019_125093 crossref_primary_10_1210_jc_2018_00890 crossref_primary_10_1055_a_2165_8262 crossref_primary_10_1530_ERC_14_0131 crossref_primary_10_1002_jcla_23823 crossref_primary_10_1210_clinem_dgad030 crossref_primary_10_3803_EnM_2024_1950 crossref_primary_10_37376_ajhas_vi2_6859 crossref_primary_10_23736_S1824_4785_21_03337_9 crossref_primary_10_12677_ACM_2021_1112862 crossref_primary_10_1097_IOP_0000000000002555 crossref_primary_10_1038_s41574_019_0305_4 crossref_primary_10_1111_cen_13107 crossref_primary_10_1038_s41533_022_00309_4 crossref_primary_10_1111_cen_13345 crossref_primary_10_3389_fendo_2020_560157 crossref_primary_10_1038_eye_2016_184 crossref_primary_10_1111_cen_13340 crossref_primary_10_1016_S1634_7358_18_91702_X |
| Cites_doi | 10.1056/NEJM199801083380201 10.1111/j.1365-2265.2004.02161.x 10.1046/j.1365-2265.2003.01862.x 10.1111/j.1365-2265.2012.04455.x 10.1210/en.2012-1452 10.1089/thy.2011.0035 10.1111/j.1365-2265.2010.03790.x 10.1111/j.1365-2265.2000.01138.x 10.1210/endo-101-4-1228 10.1210/jc.2004-0431 10.1007/BF03350368 10.1530/eje.0.1470583 10.1111/j.1365-2796.2005.01523.x 10.1111/j.1365-2265.2007.03121.x 10.1210/jc.2006-0762 10.1007/s10654-008-9255-1 10.1007/BF03343979 10.1530/eje.0.1440475 10.1089/105072502321085225 10.1530/eje.0.1460153 10.1111/cen.12106 10.4049/jimmunol.0902212 10.1210/jc.2012-1083 10.1016/j.jaut.2009.12.003 10.1016/j.ando.2012.09.008 10.1023/A:1026349702909 10.1016/j.etap.2012.09.010 10.1530/EJE-08-0386 10.1001/jama.2008.931 10.1210/jc.2008-1548 10.1089/thy.2004.14.1012 10.1001/archinte.165.14.1606 10.1001/jama.2012.13043 10.1530/eje.1.01867 10.1210/jc.2006-1824 10.1210/jc.2004-2225 10.1111/j.1365-2265.2008.03239.x 10.1046/j.1365-2265.2000.00939.x 10.1093/aje/kwm204 10.1089/thy.2012.0110 10.1007/s10552-012-0039-2 10.1016/j.canep.2012.03.013 10.1111/cen.12027 10.1007/BF03350348 10.1089/thy.2009.0023 10.1530/EJE-07-0595 10.1530/EJE-12-0356 10.1530/eje.1.01991 10.1001/archinte.162.4.439 10.1056/NEJMcp1101512 10.1093/ajcn/87.4.801 10.1001/archinte.167.13.1428 10.1038/sj.eye.6702603 10.1111/j.1365-2796.1991.tb00308.x 10.1371/journal.pone.0034979 10.1210/jc.2009-0747 10.1530/EJE-10-0785 10.1055/s-0031-1285910 10.1093/aje/kwp354 10.1136/bjo.87.6.773 10.1677/joe.0.1750571 10.1046/j.1365-2265.1996.8220832.x 10.1158/1055-9965.EPI-10-1220 10.1055/s-2006-924264 10.1124/jpet.110.169961 10.1210/jc.2009-1180 |
| ContentType | Journal Article |
| Copyright | 2013 John Wiley & Sons Ltd 2014 INIST-CNRS 2013 John Wiley & Sons Ltd. Copyright © 2013 John Wiley & Sons Ltd |
| Copyright_xml | – notice: 2013 John Wiley & Sons Ltd – notice: 2014 INIST-CNRS – notice: 2013 John Wiley & Sons Ltd. – notice: Copyright © 2013 John Wiley & Sons Ltd |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP K9. NAPCQ 7X8 |
| DOI | 10.1111/cen.12222 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-2265 |
| EndPage | 151 |
| ExternalDocumentID | 3317543751 23581474 27517202 10_1111_cen_12222 CEN12222 ark_67375_WNG_420J84FQ_C |
| Genre | reviewArticle Journal Article Review |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 08P 0R~ 10A 1OB 1OC 29B 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AAQQT AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K REN RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION IQODW AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7QP K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c5222-e267c9f2eb1975d26b4269f236edb134879f41d75c076c7933c9c0df2f98b61a3 |
| IEDL.DBID | DR2 |
| ISSN | 0300-0664 1365-2265 |
| IngestDate | Fri Jul 11 05:36:41 EDT 2025 Wed Aug 13 09:34:58 EDT 2025 Mon Jul 21 06:05:41 EDT 2025 Wed Apr 02 07:25:22 EDT 2025 Thu Apr 24 23:09:36 EDT 2025 Tue Jul 01 01:33:10 EDT 2025 Wed Jan 22 16:47:47 EST 2025 Wed Oct 30 09:55:07 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Tobacco Thyroid gland Endocrine gland Endocrinology Tobacco smoking |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 2013 John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5222-e267c9f2eb1975d26b4269f236edb134879f41d75c076c7933c9c0df2f98b61a3 |
| Notes | istex:F5BFA8EE196784C8226EB5EF9D95CC8D1EE386A3 ArticleID:CEN12222 ark:/67375/WNG-420J84FQ-C ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cen.12222 |
| PMID | 23581474 |
| PQID | 1529570361 |
| PQPubID | 36523 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1399924771 proquest_journals_1529570361 pubmed_primary_23581474 pascalfrancis_primary_27517202 crossref_primary_10_1111_cen_12222 crossref_citationtrail_10_1111_cen_12222 wiley_primary_10_1111_cen_12222_CEN12222 istex_primary_ark_67375_WNG_420J84FQ_C |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2013 |
| PublicationDateYYYYMMDD | 2013-08-01 |
| PublicationDate_xml | – month: 08 year: 2013 text: August 2013 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford |
| PublicationPlace_xml | – name: Oxford – name: England |
| PublicationTitle | Clinical endocrinology (Oxford) |
| PublicationTitleAlternate | Clin Endocrinol |
| PublicationYear | 2013 |
| Publisher | Blackwell Publishing Ltd Blackwell Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell – name: Wiley Subscription Services, Inc |
| References | Galanti, M.R., Granath, F., Cnattingius, S. et al. (2005) Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women. Journal of Internal Medicine, 258, 257-264. Vejbjerg, P., Knudsen, N., Perrild, H. et al. (2008) The impact of smoking on thyroid volume and function in relation to a shift towards iodine sufficiency. European Journal of Epidemiology, 23, 423-429. Carle, A., Bulow Pedersen, I., Knudsen, N. et al. (2012) Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population-based case-control study. European Journal of Endocrinology, 167, 483-490. Cawood, T.J., Moriarty, P., O'Farrelly, C. et al. (2007) Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biologic link. Journal of Clinical Endocrinology and Metabolism, 92, 59-64. Kim, H.K., Yoon, J.H., Kim, S.J. et al. (2013) Higher TSH level is a risk factor for differentiated thyroid cancer. Clinical Endocrinology, 78, 472-477. Pfeilschifter, J. & Ziegler, R. (1996) Smoking and endocrine ophthalmopathy: impact of smoking severity and current versus lifetime cigarette consumption. Clinical Endocrinology, 45, 477-481. Rigotti, N.A. (2012) Strategies to help a smoker who is struggling to quit. Journal of the American Medical Association, 308, 1573-1580. Cho, N.H., Choi, H.S., Kim, K.W. et al. (2010) Interaction between cigarette smoking and iodine intake and their impact on thyroid function. Clinical Endocrinology, 73, 264-270. Strieder, T.G.A., Prummel, M.F., Tijssen, J.G.P. et al. (2003) Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clinical Endocrinology, 59, 396-401. Kabat, G.C., Kim, M.Y., Wactawski-Wende, J. et al. (2012) Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiology, 36, 335-340. Melander, A., Westgren, U., Ericson, L.E. et al. (1977) Influence of the sympathetic nervous system on the secretion and metabolism of thyroid hormone. Endocrinology, 101, 1228-1237. Ittermann, T., Schmidt, C.O., Kramer, A. et al. (2008) Smoking as a risk factor for thyroid volume progression and incident goiter in a region with improved iodine supply. European Journal of Endocrinology, 159, 761-766. Caturegli, P., De Remigis, A., Ferlito, M. et al. (2012) Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology, 153, 4580-4587. Hoermann, R., Quadbeck, B., Roggenbuck, U. et al. & Basedow Study Group. (2002) Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine. Thyroid, 12, 1119-1128. Nizzi, E., Irony-Tur-Sinai, M., Lory, O. et al. (2009) Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. Journal of Immunology, 183, 6681-6688. Traisk, F., Tallstedt, L., Abraham-Nordling, M. et al. & Thyroid Study Group of TT 96. (2009) Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. Journal of Clinical Endocrinology and Metabolism, 94, 3700-3707. Holm, I.A., Manson, J.E., Michels, K.B. et al. (2005) Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Archives of Internal Medicine, 165, 1606-1611. Bufalo, N.E., Santos, R.B., Cury, A.N. et al. (2008) Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease. Clinical Endocrinology, 68, 982-98770. Ittermann, T., Thamm, M., Schipf, S. et al. (2013) Relationship of smoking and/or passive exposure to tobacco smoke on the association between serum thyroid-stimulating hormone and body mass index in large group of adolescents and children. Thyroid, 23, 262-268. Aydin, L.Y., Aydin, Y., Besir, F.H. et al. (2011) Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: the Melen study. Minerva Endocrinology, 36, 273-280. Meinhold, C.L., Ron, E., Schonfeld, S.J. et al. (2010) Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. American Journal of Epidemiology, 17, 242-252. Hou, X., Li, Y., Li, J. et al. (2011) Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees. Thyroid, 12, 1353-1358. Soldin, O.P., Goughenour, B.E., Gilbert, S.Z. et al. (2009) Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid, 19, 817-823. Gomez, J.M., Maravall, F.J., Gomez, N. et al. (2000) Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected. Clinical Endocrinology, 53, 629-634. Nedrebo, B.G., Holm, P.I., Uhlving, S. et al. (2002) Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. European Journal of Endocrinology, 147, 583-589. De Pergola, G., Ciampollilo, A., Alo, D. et al. (2010) Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin and metabolic parameters. Journal of Endocrinological Investigation, 33, 815-818. Liel, Y. (2008) Tobacco smoking and thyroid function: is weight gain a confounder? Archives of Internal Medicine, 168, 114. Effraimidis, G., Strieder, T.G.A., Tijssen, J.G.P. et al. (2011) Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. European Journal of Endocrinology, 164, 107-113. Makepeace, A.E., Bremner, A.P., O'Leary, P. et al. (2008) Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: differences between smokers and nonsmokers. Clinical Endocrinology, 69, 648-652. Mehran, L., Amouzgar, A., Delshad, H. et al. (2012) The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody. Experimental Clinical Endocrinology and Diabetes, 120, 80-83. McLeod, D.S., Watters, K.F., Carpenter, A.D. et al. (2012) Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. Journal of Clinical endocrinology and Metabolism, 97, 2682-2692. Vestergaard, P. (2002) Smoking and thyroid disorders - a meta-analysis. European Journal of Endocrinology, 146, 153-161. Krassas, G.E., Segni, M. & Wiersinga, W.M. (2005) Childhood Graves' ophthalmopathy: results of a European questionnaire study. European Journal of Endocrinology, 153, 515-521. Benedict, M.D., Missmer, S.A., Ferguson, K.K. et al. (2012) Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among non-smoking women seeking in vitro fertilization. Environmental Toxicology and Pharmacology, 34, 761-767. Mack, W.J., Preston-Martin, S., Dal Maso, L. et al. (2003) A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes and Control, 14, 773-785. Mehran, L., Amouzegar, A., Delshad, H. et al. (2012) Association between serum TSH concentration and body mass index in euthyroid subjects: the role of smoking. Archives of Iranian Medicine, 15, 400-403. Glinoer, D., de Nayer, P., Bex, M. & Belgian Collaborative Study Group on Graves' Disease. (2001) Effect of L-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. European Journal of Endocrinology, 144, 475-483. Jorde, R. & Sundsfjord, J. (2006) Serum TSH levels in smokers and non-smokers. The 5th Tromso study. Experimental Clinical Endocrinology and Diabetes, 114, 343-347. Thornton, J., Kelly, S.P., Harrison, R.A. et al. (2007) Cigarette smoking and thyroid eye disease: a systematic review. Eye, 21, 1135-1145. Wang, D.W., Zhou, R.B., Yao, Y.M. et al. (2010) Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Journal of Pharmacological and Experimental Therapy, 335, 553-561. Kapoor, D. & Jones, T.H. (2005) Smoking and hormones in health and endocrine disorders. European Journal of Endocrinology, 152, 491-499. Carle, A., Bulow Pedersen, I., Knudsen, N. et al. (2012) Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clinical Endocrinology, 77, 764-772. Knudsen, N., Laurberg, P., Rasmussen, L.B. et al. (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism, 90, 4019-4024. Fiore, M.C. & Baker, T.B. (2011) Treating smokers in the health care setting. New England Journal of Medicine, 365, 1222-1231. Barrerre, X., Valeix, P., Preziosi, P. et al. (2000) Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clinical Endocrinology, 52, 273-278. Tonacchera, M., Pinchera, A., Dimida, A. et al. (2004) Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid, 14, 1012-1019. Kitihara, C.M., Platz, E.A., Freeman, L.E. et al. (2011) Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiology, Biomarkers and prevention, 20, 464-472. Asvold, B.O., Bjoro, T. & Vatten, L.J. (2009) Association of serum TSH with high body mass differs between smokers and never-smokers. Journal of Clinical Endocrinology and Metabolism, 94, 5023-5027. Melander, A., Ljunggren, J.G., Norberg, K.A. et al. (1978) Sympathetic innervation and noradrenaline content of normal human thyroid tissue from fetal, young, and elderly subjects. Journal of End 2001; 144 2012; 120 2004; 61 2012; 167 2013; 23 2010; 17 2002; 12 2005; 258 2003; 14 2003; 59 1978; 1 2011; 12 2012; 15 2012; 97 2009; 94 2002; 146 2002; 147 2000; 52 2000; 53 2008; 69 2011; 20 2008; 23 2008; 68 2008; 159 2008; 158 2009; 19 2007; 21 2012; 23 2011; 365 2010; 73 2003; 87 2011; 164 1991; 229 2010; 34 2010; 33 2007; 167 2005; 152 2005; 153 2002; 175 2005; 90 2007; 166 2004; 89 1998; 338 2007; 92 2008; 168 2011; 36 2012; 36 1977; 101 2012; 34 2012; 77 2006; 114 2012; 73 2012; 308 2002; 25 2012; 153 2005; 165 2002; 162 2013; 78 2004; 14 2010; 335 2009; 183 2008; 87 2013 2012; 7 2009; 301 1996; 45 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 e_1_2_9_71_1 Aydin L.Y. (e_1_2_9_58_1) 2011; 36 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_37_1 Asvold B.O. (e_1_2_9_18_1) 2008; 168 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_20_1 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_60_1 e_1_2_9_2_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_70_1 e_1_2_9_38_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 Liel Y. (e_1_2_9_15_1) 2008; 168 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_67_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_65_1 e_1_2_9_7_1 e_1_2_9_5_1 e_1_2_9_3_1 Mehran L. (e_1_2_9_16_1) 2012; 15 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_69_1 e_1_2_9_29_1 |
| References_xml | – reference: Nedrebo, B.G., Holm, P.I., Uhlving, S. et al. (2002) Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. European Journal of Endocrinology, 147, 583-589. – reference: Carle, A., Bulow Pedersen, I., Knudsen, N. et al. (2012) Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clinical Endocrinology, 77, 764-772. – reference: Bulow Pedersen, I., Laurberg, P., Knudsen, N. et al. (2008) Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. European Journal of Endocrinology, 158, 367-373. – reference: Karatoprak, C., Kartal, I., Kayatas, K. et al. (2012) Does smoking affect thyroid gland enlargement and nodule formation in iodine-sufficient regions? Annales d' Endocrinologie, 73, 542-545. – reference: Metsios, G.S., Flouris, A.D., Jamurtas, A.Z. et al. (2007) A brief exposure to moderate passive smoke increases metabolism and thyroid hormone secretion. Journal of Clinical Endocrinology and Metabolism, 92, 208-211. – reference: Kitihara, C.M., Platz, E.A., Ladenson, P.W. et al. (2012) Body fatness and markers of thyroid function among U.S. men and women. PLoS ONE, 7, e34979. Doi:10.1371/journal.pone.0034979. – reference: Melander, A., Westgren, U., Ericson, L.E. et al. (1977) Influence of the sympathetic nervous system on the secretion and metabolism of thyroid hormone. Endocrinology, 101, 1228-1237. – reference: Gomez, J.M., Maravall, F.J., Gomez, N. et al. (2000) Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected. Clinical Endocrinology, 53, 629-634. – reference: Glinoer, D., de Nayer, P., Bex, M. & Belgian Collaborative Study Group on Graves' Disease. (2001) Effect of L-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study. European Journal of Endocrinology, 144, 475-483. – reference: Kitihara, C.M., Linet, M.S., Beane Freeman, L.E. et al. (2012) Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes and Control, 23, 1615-1624. – reference: Chiolero, A., Faeh, D., Paccaud, F. et al. (2008) Consequences of smoking for body weight, body fat distribution, and insulin resistance. American Journal of Clinical Nutrition, 87, 801-809. – reference: Eckstein, A., Quadbeck, B., Mueller, G. et al. (2003) Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. British Journal of Ophthalmology, 87, 773-776. – reference: Ericsson, U.B. & Lindgarde, F. (1991) Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. Journal of Internal Medicine, 229, 69-71. – reference: Nyirenda, M.J., Taylor, P.N., Stoddart, M. et al. (2009) Thyroid-stimulating hormone-receptor antibody and thyroid hormone concentrations in smokers vs nonsmokers with Graves' disease treated with carbimazole. Journal of the American Medical Association, 301, 162-164. – reference: McLeod, D.S., Watters, K.F., Carpenter, A.D. et al. (2012) Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. Journal of Clinical endocrinology and Metabolism, 97, 2682-2692. – reference: Rigotti, N.A. (2012) Strategies to help a smoker who is struggling to quit. Journal of the American Medical Association, 308, 1573-1580. – reference: Tziomalos, K. & Charsoulis, F. (2004) Endocrine effects of tobacco smoking. Clinical Endocrinology, 61, 664-674. – reference: Guignard, R., Truong, T., Rougier, Y. et al. (2007) Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a country-wide case-control study in New Caledonia. American Journal of Epidemiology, 166, 1140-1149. – reference: Kapoor, D. & Jones, T.H. (2005) Smoking and hormones in health and endocrine disorders. European Journal of Endocrinology, 152, 491-499. – reference: Effraimidis, G., Strieder, T.G.A., Tijssen, J.G.P. et al. (2011) Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. European Journal of Endocrinology, 164, 107-113. – reference: Melander, A., Ljunggren, J.G., Norberg, K.A. et al. (1978) Sympathetic innervation and noradrenaline content of normal human thyroid tissue from fetal, young, and elderly subjects. Journal of Endocrinological Investigation, 1, 175-177. – reference: Carle, A., Bulow Pedersen, I., Knudsen, N. et al. (2012) Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population-based case-control study. European Journal of Endocrinology, 167, 483-490. – reference: Aydin, L.Y., Aydin, Y., Besir, F.H. et al. (2011) Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: the Melen study. Minerva Endocrinology, 36, 273-280. – reference: Vestergaard, P. (2002) Smoking and thyroid disorders - a meta-analysis. European Journal of Endocrinology, 146, 153-161. – reference: Carle, A., Pedersen, I.B., Knudsen, N. et al. (2013) Graves' hyperthyroidism and moderate alcohol consumption: evidence for disease prevention. Clinical Endocrinology, doi:10.1111/cen.12106. – reference: Traisk, F., Tallstedt, L., Abraham-Nordling, M. et al. & Thyroid Study Group of TT 96. (2009) Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. Journal of Clinical Endocrinology and Metabolism, 94, 3700-3707. – reference: Thornton, J., Kelly, S.P., Harrison, R.A. et al. (2007) Cigarette smoking and thyroid eye disease: a systematic review. Eye, 21, 1135-1145. – reference: Fiore, M.C. & Baker, T.B. (2011) Treating smokers in the health care setting. New England Journal of Medicine, 365, 1222-1231. – reference: Barrerre, X., Valeix, P., Preziosi, P. et al. (2000) Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort. Clinical Endocrinology, 52, 273-278. – reference: Mack, W.J., Preston-Martin, S., Dal Maso, L. et al. (2003) A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes and Control, 14, 773-785. – reference: Mehran, L., Amouzgar, A., Delshad, H. et al. (2012) The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody. Experimental Clinical Endocrinology and Diabetes, 120, 80-83. – reference: Nizzi, E., Irony-Tur-Sinai, M., Lory, O. et al. (2009) Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. Journal of Immunology, 183, 6681-6688. – reference: Galanti, M.R., Granath, F., Cnattingius, S. et al. (2005) Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women. Journal of Internal Medicine, 258, 257-264. – reference: Cho, N.H., Choi, H.S., Kim, K.W. et al. (2010) Interaction between cigarette smoking and iodine intake and their impact on thyroid function. Clinical Endocrinology, 73, 264-270. – reference: Ittermann, T., Schmidt, C.O., Kramer, A. et al. (2008) Smoking as a risk factor for thyroid volume progression and incident goiter in a region with improved iodine supply. European Journal of Endocrinology, 159, 761-766. – reference: Liel, Y. (2008) Tobacco smoking and thyroid function: is weight gain a confounder? Archives of Internal Medicine, 168, 114. – reference: Caturegli, P., De Remigis, A., Ferlito, M. et al. (2012) Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology, 153, 4580-4587. – reference: De Pergola, G., Ciampollilo, A., Alo, D. et al. (2010) Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin and metabolic parameters. Journal of Endocrinological Investigation, 33, 815-818. – reference: Ittermann, T., Thamm, M., Schipf, S. et al. (2013) Relationship of smoking and/or passive exposure to tobacco smoke on the association between serum thyroid-stimulating hormone and body mass index in large group of adolescents and children. Thyroid, 23, 262-268. – reference: Arnson, Y., Shoenfeld, Y. & Amital, H. (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. Journal of Autoimmunity, 34, J258-J265. – reference: Kitihara, C.M., Platz, E.A., Freeman, L.E. et al. (2011) Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiology, Biomarkers and prevention, 20, 464-472. – reference: Holm, I.A., Manson, J.E., Michels, K.B. et al. (2005) Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Archives of Internal Medicine, 165, 1606-1611. – reference: Cawood, T.J., Moriarty, P., O'Farrelly, C. et al. (2007) Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biologic link. Journal of Clinical Endocrinology and Metabolism, 92, 59-64. – reference: Hoermann, R., Quadbeck, B., Roggenbuck, U. et al. & Basedow Study Group. (2002) Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine. Thyroid, 12, 1119-1128. – reference: Meinhold, C.L., Ron, E., Schonfeld, S.J. et al. (2010) Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. American Journal of Epidemiology, 17, 242-252. – reference: Wang, D.W., Zhou, R.B., Yao, Y.M. et al. (2010) Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. Journal of Pharmacological and Experimental Therapy, 335, 553-561. – reference: Vejbjerg, P., Knudsen, N., Perrild, H. et al. (2008) The impact of smoking on thyroid volume and function in relation to a shift towards iodine sufficiency. European Journal of Epidemiology, 23, 423-429. – reference: Makepeace, A.E., Bremner, A.P., O'Leary, P. et al. (2008) Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: differences between smokers and nonsmokers. Clinical Endocrinology, 69, 648-652. – reference: Asvold, B.O., Bjoro, T. & Vatten, L.J. (2009) Association of serum TSH with high body mass differs between smokers and never-smokers. Journal of Clinical Endocrinology and Metabolism, 94, 5023-5027. – reference: Bartalena, L., Marcocci, C., Bogazzi, F. et al. (1998) Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. New England Journal of Medicine, 338, 73-78. – reference: Tonacchera, M., Pinchera, A., Dimida, A. et al. (2004) Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid, 14, 1012-1019. – reference: Knudsen, N., Bulow, I., Laurberg, P. et al. (2002) High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study. Journal of Endocrinology, 175, 571-576. – reference: Kabat, G.C., Kim, M.Y., Wactawski-Wende, J. et al. (2012) Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiology, 36, 335-340. – reference: Asvold, B.O., Bjoro, T., Nilsen, T.I. et al. (2008) Tobacco smoking and thyroid function: is weight gain a confounder? In reply. Archives of Internal Medicine, 168, 114. – reference: Bufalo, N.E., Santos, R.B., Cury, A.N. et al. (2008) Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease. Clinical Endocrinology, 68, 982-98770. – reference: Effraimidis, G., Tijssen, J.G.P. & Wiersinga, W.M. (2009) Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. Journal of Clinical Endocrinology and Metabolism, 94, 1324-1328. – reference: Benedict, M.D., Missmer, S.A., Ferguson, K.K. et al. (2012) Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among non-smoking women seeking in vitro fertilization. Environmental Toxicology and Pharmacology, 34, 761-767. – reference: Jorde, R. & Sundsfjord, J. (2006) Serum TSH levels in smokers and non-smokers. The 5th Tromso study. Experimental Clinical Endocrinology and Diabetes, 114, 343-347. – reference: Soldin, O.P., Goughenour, B.E., Gilbert, S.Z. et al. (2009) Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid, 19, 817-823. – reference: Knudsen, N., Laurberg, P., Rasmussen, L.B. et al. (2005) Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism, 90, 4019-4024. – reference: Krassas, G.E., Segni, M. & Wiersinga, W.M. (2005) Childhood Graves' ophthalmopathy: results of a European questionnaire study. European Journal of Endocrinology, 153, 515-521. – reference: Strieder, T.G.A., Prummel, M.F., Tijssen, J.G.P. et al. (2003) Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clinical Endocrinology, 59, 396-401. – reference: Asvold, B.O., Bjoro, T., Nilsen, T.I. et al. (2007) Tobacco smoking and thyroid function: a population-based study. Archives of Internal Medicine, 167, 1428-1432. – reference: Kim, H.K., Yoon, J.H., Kim, S.J. et al. (2013) Higher TSH level is a risk factor for differentiated thyroid cancer. Clinical Endocrinology, 78, 472-477. – reference: Pfeilschifter, J. & Ziegler, R. (1996) Smoking and endocrine ophthalmopathy: impact of smoking severity and current versus lifetime cigarette consumption. Clinical Endocrinology, 45, 477-481. – reference: Belin, R.M., Astor, B.C., Powe, N.R. et al. (2004) Smokers have high serum antithyroid antibody and thyrotropin concentrations less often and low serum thyrotropin concentrations more often than nonsmokers. Journal of Clinical Endocrinology and Metabolism, 89, 6077-6086. – reference: Knudsen, N., Bulow, I., Laurberg, P. et al. (2002) Association of tobacco smoking with goiter in a low-iodine-intake area. Archives of Internal Medicine, 162, 439-443. – reference: Kimball, L.E., Kulinskaya, E., Brown, B. et al. (2002) Does smoking increase relapse rates in Graves' disease? Journal of Endocrinological investigation, 25, 152-157. – reference: Mehran, L., Amouzegar, A., Delshad, H. et al. (2012) Association between serum TSH concentration and body mass index in euthyroid subjects: the role of smoking. Archives of Iranian Medicine, 15, 400-403. – reference: Hou, X., Li, Y., Li, J. et al. (2011) Development of thyroid dysfunction and autoantibodies in Graves' multiplex families: an eight-year follow-up study in Chinese Han pedigrees. Thyroid, 12, 1353-1358. – volume: 14 start-page: 1012 year: 2004 end-page: 1019 article-title: Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter publication-title: Thyroid – volume: 15 start-page: 400 year: 2012 end-page: 403 article-title: Association between serum TSH concentration and body mass index in euthyroid subjects: the role of smoking publication-title: Archives of Iranian Medicine – volume: 335 start-page: 553 year: 2010 end-page: 561 article-title: Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro publication-title: Journal of Pharmacological and Experimental Therapy – volume: 36 start-page: 273 year: 2011 end-page: 280 article-title: Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: the Melen study publication-title: Minerva Endocrinology – volume: 92 start-page: 208 year: 2007 end-page: 211 article-title: A brief exposure to moderate passive smoke increases metabolism and thyroid hormone secretion publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 20 start-page: 464 year: 2011 end-page: 472 article-title: Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies publication-title: Cancer Epidemiology, Biomarkers and prevention – volume: 167 start-page: 1428 year: 2007 end-page: 1432 article-title: Tobacco smoking and thyroid function: a population‐based study publication-title: Archives of Internal Medicine – volume: 19 start-page: 817 year: 2009 end-page: 823 article-title: Thyroid hormone levels associated with active and passive cigarette smoking publication-title: Thyroid – volume: 90 start-page: 4019 year: 2005 end-page: 4024 article-title: Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 168 start-page: 114 year: 2008 article-title: Tobacco smoking and thyroid function: is weight gain a confounder? In reply publication-title: Archives of Internal Medicine – volume: 94 start-page: 1324 year: 2009 end-page: 1328 article-title: Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 34 start-page: 761 year: 2012 end-page: 767 article-title: Secondhand tobacco smoke exposure is associated with prolactin but not thyroid stimulating hormone among non‐smoking women seeking in vitro fertilization publication-title: Environmental Toxicology and Pharmacology – volume: 94 start-page: 3700 year: 2009 end-page: 3707 article-title: Thyroid‐associated ophthalmopathy after treatment for Graves’ hyperthyroidism with antithyroid drugs or iodine‐131 publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 167 start-page: 483 year: 2012 end-page: 490 article-title: Moderate alcohol consumption may protect against overt autoimmune hypothyroidism: a population‐based case‐control study publication-title: European Journal of Endocrinology – volume: 59 start-page: 396 year: 2003 end-page: 401 article-title: Risk factors for and prevalence of thyroid disorders in a cross‐sectional study among healthy female relatives of patients with autoimmune thyroid disease publication-title: Clinical Endocrinology – volume: 17 start-page: 242 year: 2010 end-page: 252 article-title: Nonradiation risk factors for thyroid cancer in the US radiologic technologists study publication-title: American Journal of Epidemiology – volume: 94 start-page: 5023 year: 2009 end-page: 5027 article-title: Association of serum TSH with high body mass differs between smokers and never‐smokers publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 308 start-page: 1573 year: 2012 end-page: 1580 article-title: Strategies to help a smoker who is struggling to quit publication-title: Journal of the American Medical Association – volume: 338 start-page: 73 year: 1998 end-page: 78 article-title: Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy publication-title: New England Journal of Medicine – volume: 14 start-page: 773 year: 2003 end-page: 785 article-title: A pooled analysis of case‐control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea publication-title: Cancer Causes and Control – volume: 23 start-page: 1615 year: 2012 end-page: 1624 article-title: Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States publication-title: Cancer Causes and Control – volume: 21 start-page: 1135 year: 2007 end-page: 1145 article-title: Cigarette smoking and thyroid eye disease: a systematic review publication-title: Eye – volume: 158 start-page: 367 year: 2008 end-page: 373 article-title: Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study publication-title: European Journal of Endocrinology – volume: 12 start-page: 1119 year: 2002 end-page: 1128 article-title: Relapse of Graves’ disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine publication-title: Thyroid – volume: 36 start-page: 335 year: 2012 end-page: 340 article-title: Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women publication-title: Cancer Epidemiology – volume: 114 start-page: 343 year: 2006 end-page: 347 article-title: Serum TSH levels in smokers and non‐smokers. The 5th Tromso study publication-title: Experimental Clinical Endocrinology and Diabetes – volume: 162 start-page: 439 year: 2002 end-page: 443 article-title: Association of tobacco smoking with goiter in a low‐iodine‐intake area publication-title: Archives of Internal Medicine – volume: 229 start-page: 69 year: 1991 end-page: 71 article-title: Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis publication-title: Journal of Internal Medicine – volume: 73 start-page: 264 year: 2010 end-page: 270 article-title: Interaction between cigarette smoking and iodine intake and their impact on thyroid function publication-title: Clinical Endocrinology – volume: 165 start-page: 1606 year: 2005 end-page: 1611 article-title: Smoking and other lifestyle factors and the risk of Graves’ hyperthyroidism publication-title: Archives of Internal Medicine – volume: 101 start-page: 1228 year: 1977 end-page: 1237 article-title: Influence of the sympathetic nervous system on the secretion and metabolism of thyroid hormone publication-title: Endocrinology – volume: 168 start-page: 114 year: 2008 article-title: Tobacco smoking and thyroid function: is weight gain a confounder? publication-title: Archives of Internal Medicine – volume: 1 start-page: 175 year: 1978 end-page: 177 article-title: Sympathetic innervation and noradrenaline content of normal human thyroid tissue from fetal, young, and elderly subjects publication-title: Journal of Endocrinological Investigation – volume: 12 start-page: 1353 year: 2011 end-page: 1358 article-title: Development of thyroid dysfunction and autoantibodies in Graves’ multiplex families: an eight‐year follow‐up study in Chinese Han pedigrees publication-title: Thyroid – volume: 147 start-page: 583 year: 2002 end-page: 589 article-title: Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves’ disease publication-title: European Journal of Endocrinology – volume: 152 start-page: 491 year: 2005 end-page: 499 article-title: Smoking and hormones in health and endocrine disorders publication-title: European Journal of Endocrinology – volume: 144 start-page: 475 year: 2001 end-page: 483 article-title: Effect of L‐thyroxine administration, TSH‐receptor antibodies and smoking on the risk of recurrence in Graves’ hyperthyroidism treated with antithyroid drugs: a double‐blind prospective randomized study publication-title: European Journal of Endocrinology – volume: 33 start-page: 815 year: 2010 end-page: 818 article-title: Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin and metabolic parameters publication-title: Journal of Endocrinological Investigation – volume: 258 start-page: 257 year: 2005 end-page: 264 article-title: Cigarette smoking and the risk of goitre and thyroid nodules amongst parous women publication-title: Journal of Internal Medicine – volume: 78 start-page: 472 year: 2013 end-page: 477 article-title: Higher TSH level is a risk factor for differentiated thyroid cancer publication-title: Clinical Endocrinology – volume: 7 start-page: e34979 year: 2012 article-title: Body fatness and markers of thyroid function among U.S. men and women publication-title: PLoS ONE – volume: 68 start-page: 982 year: 2008 end-page: 98770 article-title: Genetic polymorphisms associated with cigarette smoking and the risk of Graves’ disease publication-title: Clinical Endocrinology – volume: 164 start-page: 107 year: 2011 end-page: 113 article-title: Natural history of the transition from euthyroidism to overt autoimmune hypo‐ or hyperthyroidism: a prospective study publication-title: European Journal of Endocrinology – volume: 120 start-page: 80 year: 2012 end-page: 83 article-title: The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody publication-title: Experimental Clinical Endocrinology and Diabetes – volume: 69 start-page: 648 year: 2008 end-page: 652 article-title: Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: differences between smokers and nonsmokers publication-title: Clinical Endocrinology – volume: 166 start-page: 1140 year: 2007 end-page: 1149 article-title: Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a country‐wide case‐control study in New Caledonia publication-title: American Journal of Epidemiology – volume: 92 start-page: 59 year: 2007 end-page: 64 article-title: Smoking and thyroid‐associated ophthalmopathy: a novel explanation of the biologic link publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 153 start-page: 515 year: 2005 end-page: 521 article-title: Childhood Graves’ ophthalmopathy: results of a European questionnaire study publication-title: European Journal of Endocrinology – volume: 77 start-page: 764 year: 2012 end-page: 772 article-title: Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism – a population‐based, case‐control study publication-title: Clinical Endocrinology – volume: 34 start-page: J258 year: 2010 end-page: J265 article-title: Effects of tobacco smoke on immunity, inflammation and autoimmunity publication-title: Journal of Autoimmunity – volume: 53 start-page: 629 year: 2000 end-page: 634 article-title: Determinants of thyroid volume as measured by ultrasonography in healthy adults randomly selected publication-title: Clinical Endocrinology – volume: 52 start-page: 273 year: 2000 end-page: 278 article-title: Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort publication-title: Clinical Endocrinology – volume: 159 start-page: 761 year: 2008 end-page: 766 article-title: Smoking as a risk factor for thyroid volume progression and incident goiter in a region with improved iodine supply publication-title: European Journal of Endocrinology – volume: 89 start-page: 6077 year: 2004 end-page: 6086 article-title: Smokers have high serum antithyroid antibody and thyrotropin concentrations less often and low serum thyrotropin concentrations more often than nonsmokers publication-title: Journal of Clinical Endocrinology and Metabolism – volume: 183 start-page: 6681 year: 2009 end-page: 6688 article-title: Activation of the cholinergic anti‐inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses publication-title: Journal of Immunology – volume: 25 start-page: 152 year: 2002 end-page: 157 article-title: Does smoking increase relapse rates in Graves’ disease? publication-title: Journal of Endocrinological investigation – volume: 23 start-page: 423 year: 2008 end-page: 429 article-title: The impact of smoking on thyroid volume and function in relation to a shift towards iodine sufficiency publication-title: European Journal of Epidemiology – volume: 45 start-page: 477 year: 1996 end-page: 481 article-title: Smoking and endocrine ophthalmopathy: impact of smoking severity and current versus lifetime cigarette consumption publication-title: Clinical Endocrinology – volume: 301 start-page: 162 year: 2009 end-page: 164 article-title: Thyroid‐stimulating hormone‐receptor antibody and thyroid hormone concentrations in smokers vs nonsmokers with Graves’ disease treated with carbimazole publication-title: Journal of the American Medical Association – volume: 97 start-page: 2682 year: 2012 end-page: 2692 article-title: Thyrotropin and thyroid cancer diagnosis: a systematic review and dose‐response meta‐analysis publication-title: Journal of Clinical endocrinology and Metabolism – volume: 146 start-page: 153 year: 2002 end-page: 161 article-title: Smoking and thyroid disorders – a meta‐analysis publication-title: European Journal of Endocrinology – volume: 175 start-page: 571 year: 2002 end-page: 576 article-title: High occurrence of thyroid multinodularity and low occurrence of subclinical hypothyroidism among tobacco smokers in a large population study publication-title: Journal of Endocrinology – volume: 61 start-page: 664 year: 2004 end-page: 674 article-title: Endocrine effects of tobacco smoking publication-title: Clinical Endocrinology – volume: 87 start-page: 801 year: 2008 end-page: 809 article-title: Consequences of smoking for body weight, body fat distribution, and insulin resistance publication-title: American Journal of Clinical Nutrition – year: 2013 article-title: Graves’ hyperthyroidism and moderate alcohol consumption: evidence for disease prevention publication-title: Clinical Endocrinology – volume: 73 start-page: 542 year: 2012 end-page: 545 article-title: Does smoking affect thyroid gland enlargement and nodule formation in iodine‐sufficient regions? publication-title: Annales d’ Endocrinologie – volume: 153 start-page: 4580 year: 2012 end-page: 4587 article-title: Anatabine ameliorates experimental autoimmune thyroiditis publication-title: Endocrinology – volume: 23 start-page: 262 year: 2013 end-page: 268 article-title: Relationship of smoking and/or passive exposure to tobacco smoke on the association between serum thyroid‐stimulating hormone and body mass index in large group of adolescents and children publication-title: Thyroid – volume: 87 start-page: 773 year: 2003 end-page: 776 article-title: Impact of smoking on the response to treatment of thyroid associated ophthalmopathy publication-title: British Journal of Ophthalmology – volume: 365 start-page: 1222 year: 2011 end-page: 1231 article-title: Treating smokers in the health care setting publication-title: New England Journal of Medicine – ident: e_1_2_9_43_1 doi: 10.1056/NEJM199801083380201 – ident: e_1_2_9_3_1 doi: 10.1111/j.1365-2265.2004.02161.x – ident: e_1_2_9_24_1 doi: 10.1046/j.1365-2265.2003.01862.x – ident: e_1_2_9_28_1 doi: 10.1111/j.1365-2265.2012.04455.x – ident: e_1_2_9_32_1 doi: 10.1210/en.2012-1452 – ident: e_1_2_9_38_1 doi: 10.1089/thy.2011.0035 – ident: e_1_2_9_22_1 doi: 10.1111/j.1365-2265.2010.03790.x – ident: e_1_2_9_50_1 doi: 10.1111/j.1365-2265.2000.01138.x – ident: e_1_2_9_20_1 doi: 10.1210/endo-101-4-1228 – ident: e_1_2_9_5_1 doi: 10.1210/jc.2004-0431 – ident: e_1_2_9_21_1 doi: 10.1007/BF03350368 – ident: e_1_2_9_41_1 doi: 10.1530/eje.0.1470583 – ident: e_1_2_9_57_1 doi: 10.1111/j.1365-2796.2005.01523.x – ident: e_1_2_9_69_1 doi: 10.1111/j.1365-2265.2007.03121.x – ident: e_1_2_9_11_1 doi: 10.1210/jc.2006-0762 – ident: e_1_2_9_19_1 doi: 10.1007/s10654-008-9255-1 – ident: e_1_2_9_40_1 doi: 10.1007/BF03343979 – ident: e_1_2_9_39_1 doi: 10.1530/eje.0.1440475 – ident: e_1_2_9_42_1 doi: 10.1089/105072502321085225 – ident: e_1_2_9_2_1 doi: 10.1530/eje.0.1460153 – ident: e_1_2_9_36_1 doi: 10.1111/cen.12106 – volume: 168 start-page: 114 year: 2008 ident: e_1_2_9_15_1 article-title: Tobacco smoking and thyroid function: is weight gain a confounder? publication-title: Archives of Internal Medicine – ident: e_1_2_9_31_1 doi: 10.4049/jimmunol.0902212 – ident: e_1_2_9_66_1 doi: 10.1210/jc.2012-1083 – ident: e_1_2_9_47_1 doi: 10.1016/j.jaut.2009.12.003 – ident: e_1_2_9_51_1 doi: 10.1016/j.ando.2012.09.008 – ident: e_1_2_9_59_1 doi: 10.1023/A:1026349702909 – ident: e_1_2_9_10_1 doi: 10.1016/j.etap.2012.09.010 – ident: e_1_2_9_53_1 doi: 10.1530/EJE-08-0386 – ident: e_1_2_9_37_1 doi: 10.1001/jama.2008.931 – ident: e_1_2_9_26_1 doi: 10.1210/jc.2008-1548 – ident: e_1_2_9_54_1 doi: 10.1089/thy.2004.14.1012 – ident: e_1_2_9_35_1 doi: 10.1001/archinte.165.14.1606 – ident: e_1_2_9_71_1 doi: 10.1001/jama.2012.13043 – ident: e_1_2_9_4_1 doi: 10.1530/eje.1.01867 – volume: 15 start-page: 400 year: 2012 ident: e_1_2_9_16_1 article-title: Association between serum TSH concentration and body mass index in euthyroid subjects: the role of smoking publication-title: Archives of Iranian Medicine – ident: e_1_2_9_48_1 doi: 10.1210/jc.2006-1824 – volume: 36 start-page: 273 year: 2011 ident: e_1_2_9_58_1 article-title: Effect of smoking intensity on thyroid volume, thyroid nodularity and thyroid function: the Melen study publication-title: Minerva Endocrinology – ident: e_1_2_9_13_1 doi: 10.1210/jc.2004-2225 – ident: e_1_2_9_17_1 doi: 10.1111/j.1365-2265.2008.03239.x – ident: e_1_2_9_49_1 doi: 10.1046/j.1365-2265.2000.00939.x – ident: e_1_2_9_63_1 doi: 10.1093/aje/kwm204 – ident: e_1_2_9_9_1 doi: 10.1089/thy.2012.0110 – ident: e_1_2_9_62_1 doi: 10.1007/s10552-012-0039-2 – ident: e_1_2_9_61_1 doi: 10.1016/j.canep.2012.03.013 – ident: e_1_2_9_67_1 doi: 10.1111/cen.12027 – volume: 168 start-page: 114 year: 2008 ident: e_1_2_9_18_1 article-title: Tobacco smoking and thyroid function: is weight gain a confounder? In reply publication-title: Archives of Internal Medicine – ident: e_1_2_9_12_1 doi: 10.1007/BF03350348 – ident: e_1_2_9_8_1 doi: 10.1089/thy.2009.0023 – ident: e_1_2_9_25_1 doi: 10.1530/EJE-07-0595 – ident: e_1_2_9_29_1 doi: 10.1530/EJE-12-0356 – ident: e_1_2_9_34_1 doi: 10.1530/eje.1.01991 – ident: e_1_2_9_52_1 doi: 10.1001/archinte.162.4.439 – ident: e_1_2_9_70_1 doi: 10.1056/NEJMcp1101512 – ident: e_1_2_9_68_1 doi: 10.1093/ajcn/87.4.801 – ident: e_1_2_9_7_1 doi: 10.1001/archinte.167.13.1428 – ident: e_1_2_9_45_1 doi: 10.1038/sj.eye.6702603 – ident: e_1_2_9_55_1 doi: 10.1111/j.1365-2796.1991.tb00308.x – ident: e_1_2_9_65_1 doi: 10.1371/journal.pone.0034979 – ident: e_1_2_9_44_1 doi: 10.1210/jc.2009-0747 – ident: e_1_2_9_27_1 doi: 10.1530/EJE-10-0785 – ident: e_1_2_9_23_1 doi: 10.1055/s-0031-1285910 – ident: e_1_2_9_60_1 doi: 10.1093/aje/kwp354 – ident: e_1_2_9_46_1 doi: 10.1136/bjo.87.6.773 – ident: e_1_2_9_56_1 doi: 10.1677/joe.0.1750571 – ident: e_1_2_9_33_1 doi: 10.1046/j.1365-2265.1996.8220832.x – ident: e_1_2_9_64_1 doi: 10.1158/1055-9965.EPI-10-1220 – ident: e_1_2_9_6_1 doi: 10.1055/s-2006-924264 – ident: e_1_2_9_30_1 doi: 10.1124/jpet.110.169961 – ident: e_1_2_9_14_1 doi: 10.1210/jc.2009-1180 |
| SSID | ssj0005807 |
| Score | 2.5339139 |
| SecondaryResourceType | review_article |
| Snippet | Summary
Current smoking in population surveys is associated with a slight dose‐dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3... Current smoking in population surveys is associated with a slight dose‐dependent fall of serum TSH , likely secondary to a rise of serum FT 4 and FT 3 induced... Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3 induced by... Summary Current smoking in population surveys is associated with a slight dose-dependent fall of serum TSH, likely secondary to a rise of serum FT4 and FT3... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 145 |
| SubjectTerms | Adult Biological and medical sciences Body Mass Index Endocrinopathies Female Fundamental and applied biological sciences. Psychology Goiter - etiology Hashimoto Disease - prevention & control Humans Hypothyroidism - prevention & control Male Medical sciences Organ Size Smoking - adverse effects Thyroid Diseases - etiology Thyroid Gland - anatomy & histology Thyroid Gland - physiology Thyroid Neoplasms - etiology Thyroiditis, Autoimmune Thyrotropin - blood Tobacco, tobacco smoking Toxicology Vertebrates: endocrinology |
| Title | Smoking and thyroid |
| URI | https://api.istex.fr/ark:/67375/WNG-420J84FQ-C/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcen.12222 https://www.ncbi.nlm.nih.gov/pubmed/23581474 https://www.proquest.com/docview/1529570361 https://www.proquest.com/docview/1399924771 |
| Volume | 79 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEB9EQXxp_aznF2eR0pc9NtlssotPcngVwYNqpT4IIclmQc7uyX1A6V_vzH7piYXSt4WdBCYzk8wkM78BOHGWSQIyC5RXIhCZtQHqjQmixIqYeWoIT_cdV0N5cSsu7-K7JThtamEqfIj2wo0so9yvycCNnb4ycueLHsPTjfZfytUih-j6BToqrkulI6qcllLUqEKUxdOOXDiLVmhZf1NupJni8uRVX4v3HM9FP7Y8iAYf4b5hoco_GfXmM9tzf96gO_4nj-vwoXZQu2eVRm3Aki82YfWqfoLfgs2bX2O6Xu-aIuuilCfjh2wbbgfnP_oXQd1ZIXDob_HAc6lcmnPcqFMVZ1xaqmjNeSR9ZlmEQUyaC5ap2IVKOjThyKUuzHKep4mVzEQ7sFyMC78LXZ_mSW6kFwbjW_xOMIAx3ieWhRm3PO3A12aNtathx6n7xaNuwg9kUpdMduBzS_pUYW28R_SlFFRLYSYjSk5Tsf45_KYFDy8TMfiu-x04WpBkO4CrGL22EGc6aESra8OdakYPnwRKxjpw3P5Gk6N3FFP48Rxp0KnDsFUppPlUqcTL5IQnJ5RAtkvB_p0R3T8flh97_066D2u8bMdBCYgHsDybzP0hOkUze1Rq_zMHXAGG |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB9KC9UXta22p7WeRcSXPTbZbLILvsjR86y9A7XFvkhIslko1T253oH41zuT_WivVBDfFnYSmEwmmZnM_AbglbNMEpBZpLwSkSisjXDfmCjJrEiZp4bwFO-YTOX4TByfp-dr8LathanxIbqAG2lGOK9JwSkgfUPLna8GDK83PIA3qKN3cKg-X4NHpU2xdEK101KKBleI8ni6oSu30QYt7C_KjjRXuEBl3dniLtNz1ZINV9HoIXxrmagzUC4Hy4UduN-38B3_l8tH8KCxUfvv6k21BWu-2obNSfMKvwPbX37MKMLeN1XRR0HPZxfFYzgbHZ0Ox1HTXCFyaHLxyHOpXF5yPKtzlRZcWipqLXkifWFZgn5MXgpWqNTFSjrU4sTlLi5KXuaZlcwkT2C9mlV-D_o-L7PSSC8Murj4naEPY7zPLIsLbnnegzftImvXII9TA4zvuvVAkEkdmOzBYUf6s4bbuIvodZBUR2Hml5SfplL9dfpeCx4fZ2L0SQ97cLAiym4AVykabjHOtN_KVje6e6UZvX0SLhnrwcvuN2odPaWYys-WSIN2HXquSiHNbr0nricnSDmhBLIdJPt3RvTwaBo-nv476Qu4Nz6dnOiTD9OPz-A-D905KB9xH9YX86V_jjbSwh4EVfgDJEcFoQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3raxQxEB9KC8UvPurraq2niPhlj002m-ziJ7n2rNUevor9UAh5gtTulesdiH-9M_uqJxXEbws7CUxmJplJZn4D8NxZJgnILFFBiUR4axPUG5NkhRU5C9QQnu47jqby4FgcnuQna_Cqq4Vp8CH6CzeyjHq_JgO_8PE3I3ehGjE83XD_3RAyLUil9z5dYUflba10RqXTUooWVojSePqhK4fRBq3rD0qONJe4PrFpbHGd57nqyNYn0eQWnHY8NAkoZ6Plwo7czz_gHf-Tydtws_VQh68blboDa6Hags2j9g3-Lmx9Pp_R_frQVH6IYp7Pvvl7cDzZ_zI-SNrWColDh4sngUvlyshxpy5V7rm0VNIaeSaDtyzDKKaMgnmVu1RJhzacudKlPvJYFlYyk92H9WpWhYcwDGUsopFBGAxw8bvACMaEUFiWem55OYCX3Rpr1-KOU_uL77qLP5BJXTM5gGc96UUDtnEd0YtaUD2FmZ9RdprK9dfpGy14eliIyUc9HsDuiiT7AVzl6LalONNOJ1rdWu6lZvTySahkbABP-99oc_SQYqowWyINenUYtyqFNA8albianADlhBLIdi3YvzOix_vT-mP730mfwOaHvYl-_3b67hHc4HVrDkpG3IH1xXwZHqODtLC7tSH8AiLEBFk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Smoking+and+thyroid&rft.jtitle=Clinical+endocrinology+%28Oxford%29&rft.au=Wiersinga%2C+Wilmar+M.&rft.date=2013-08-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0300-0664&rft.eissn=1365-2265&rft.volume=79&rft.issue=2&rft.spage=145&rft.epage=151&rft_id=info:doi/10.1111%2Fcen.12222&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_420J84FQ_C |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0664&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0664&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0664&client=summon |